Literature DB >> 3814422

The vicryl tie technique for inserting a draining implant in the treatment of secondary glaucoma.

A C Molteno, P J Polkinghorne, J A Bowbyes.   

Abstract

We have previously described surgical techniques for draining severe cases of secondary glaucoma by means of an artificial implant. Wherever possible these implants have been inserted in two stages. The technique involved suturing the episcleral plates of the implant to the sclera without connecting them to the chamber as the first procedure. Following this procedure the presence of the plates cause the surrounding tissue to form a thin fibrous envelope called a preformed bleb cavity. After a suitable interval of between six and eight weeks the connecting tube of the implant was inserted into the anterio chamber so as to drain aqueous into this preformed bleb cavity. This manoeuvre drastically reduced the incidence of postoperative hypotony and has proved a safe and effective technique. This communication reports an improvement on this technique in which the connecting tube of the implant is occluded by a ligature of 5-0 vicryl before inserting the tube into the anterior chamber through a fine needle puncture, at the same time as the episcleral plates of the implant are sutured to the sclera. The effect of this procedure is thus to prevent any drainage of aqueous until three to five weeks after operation when the vicryl suture material dissolves, allowing aqueous to drain into the preformed bleb system lined by a thin layer of dense fibrous tissue. This technique provides the advantages of the previous two-stage technique without the need for a second operation. The surgical technique is described together with the results of treating a series of 20 eyes with severe secondary glaucoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3814422     DOI: 10.1111/j.1442-9071.1986.tb00470.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  14 in total

1.  Survival analysis for success of Molteno tube implants.

Authors:  D C Broadway; M Iester; M Schulzer; G R Douglas
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  A one-piece ocular drainage implant for glaucoma surgery: a preliminary report.

Authors:  M Kivalo; C Raitta; T Mononen
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

Review 3.  Glaucoma drainage devices; past, present, and future.

Authors:  K S Lim; B D Allan; A W Lloyd; A Muir; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

4.  Single stage insertion of the Molteno tube for glaucoma and modifications to reduce postoperative hypotony.

Authors:  J E Hoare Nairne; D Sherwood; J S Jacob; W J Rich
Journal:  Br J Ophthalmol       Date:  1988-11       Impact factor: 4.638

5.  Control and optimisation of fluid flow in glaucoma drainage device surgery.

Authors:  Kin Sheng Lim
Journal:  Eye (Lond)       Date:  2018-01-19       Impact factor: 3.775

6.  Transvitreal endocyclophotocoagulation.

Authors:  J A Haller
Journal:  Trans Am Ophthalmol Soc       Date:  1996

7.  Otago Glaucoma Surgery Outcome Study: long term results of cataract extraction combined with Molteno implant insertion or trabeculectomy in primary glaucoma.

Authors:  A C B Molteno; K W Whittaker; T H Bevin; P Herbison
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

8.  [The Ahmed glaucoma valve. Medium term results].

Authors:  K Hille; M Rossi; A Hille; K W Ruprecht
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

9.  Combined Baerveldt glaucoma drainage implant surgery and surgical bleb revision for preventing a postoperative hypertensive phase.

Authors:  Motofumi Kawai; Toru Yamaguchi; Seigo Nakabayashi; Akitoshi Yoshida
Journal:  Clin Ophthalmol       Date:  2014-04-16

10.  Performance of and Pressure Elevation Formed by Small-diameter Microtubes Used in Constant-flow Sets.

Authors:  Sae Woon Sohn; Myounggyu D Noh; Jong-Hyun Lee; Kyoung Nam Kim; Chang-Sik Kim; Byung Heon Ahn
Journal:  Korean J Ophthalmol       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.